Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000861177-07-000003
Filing Date
2007-02-15
Accepted
2007-02-15 15:19:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 allergan_agform.txt SC 13G/A 8291
  Complete submission text file 0000861177-07-000003.txt   10327
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Subject) CIK: 0000850693 (see all company filings)

EIN.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-40724 | Film No.: 07627058
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE NORTH WACKER DRIVE CHICAGO IL 60606
Business Address ONE NORTH WACKER DRIVE CHICAGO IL 60606
UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (Filed by) CIK: 0000861177 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000